NCT Number: NCT00226928
Psychosocial Treatment for Improving Chances of Survival in Women With Breast Cancer
This study will investigate the influence of psychosocial treatment on psychological outcomes and survival among women with metastatic or recurrent breast cancer.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
About this study
The objective of this study is to investigate the influence of psychosocial treatment on psychological outcomes and survival among women with metastatic/recurrent breast cancer.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Women were eligible for the study if they had documented metastatic or recurrent breast cancer, were proficient enough in English to be able to complete questionnaires and participate in a support group, were living in the Greater San Francisco Bay Area, and had a Karnofsky score of at least 70%.19 Exclusion Criteria:
Women were excluded if they had any of the following risk factors: positive supraclavicular lymph nodes as the only metastatic lesion at the time of initial diagnosis; active non-breast cancers within the past 10 years; or other concurrent medical conditions likely to influence short-term survival. Basal cell or squamous cell carcinomas of the skin, in situ cancer of the cervix, or melanoma with a Breslow depth less than 0.76 mm were allowed.
Treatment and study plan
Education
BehavioralSponsors and collaborators
Lead sponsor
Stanford University
Other
Collaborators
- National Institute of Mental Health (NIMH)
Registry information
Official study title
Psychosocial Treatment Effects on Cancer Survival
Important dates
- Study completion
- 2005
- First posted
- Sep 27, 2005
- Registry last updated
- Dec 4, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer
NCT06570031
Breast Diseases, Breast Neoplasms
Nagoya, Aichi-ken, Japan
View Trial DetailsCirculating miRNAs.
NCT01722851
Breast Cancer, Breast Diseases
Cork, Ireland
View Trial DetailsA Study of LY2880070 in Participants With Advanced or Metastatic Cancer
NCT02632448
Adnexal Diseases, Breast Cancer
Boston, Massachusetts, United States
View Trial DetailsPhase 2 Study of the Monoclonal Antibody MGAH22 (Margetuximab) in Patients With Relapsed or Refractory Advanced Breast Cancer
NCT01828021
Breast Cancer, Breast Diseases
San Francisco, California, United States
View Trial Details